Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KDT-3594 vs Pramipexole in Early Parkinson's Disease
NCT03845387Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of matsupexole in Parkinson's disease (PD), sponsored by Kissei Pharmaceutical Co., Ltd.. Started Feb 2019; status: completed.
02
Drugs
matsupexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03845387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03845387.